Mirtazapine Tablet, Film Coated
Product Images NDC 55154-7297

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-7297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dd924fb7 0484 4b62 8522 9f67d1416919 00

Dd924fb7 0484 4b62 8522 9f67d1416919 00
This is a pack of Mirtazapine Tablets, USP, containing 10 tablets of 15 mg each. The packaging contains instructions to store the medication in a tight, light-resistant container at a temperature between 20°C to 25°C. The unit dose of this package is not child-resistant and is intended for institutional use only. It is manufactured and distributed by Apotex Corp and Major Pharmaceuticals, respectively. For detailed dosage guidelines, precautions, and warnings, one can refer to the product insert found at www.majorpharmaceuticals.com.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.